1. Home
  2. ULBI vs ACHV Comparison

ULBI vs ACHV Comparison

Compare ULBI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

N/A

Current Price

$5.56

Market Cap

102.1M

Sector

Miscellaneous

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.49

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ULBI
ACHV
Founded
1990
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.1M
726.5M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
ULBI
ACHV
Price
$5.56
$7.49
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.67
AVG Volume (30 Days)
31.8K
1.5M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
13.00
N/A
Revenue
$191,159,000.00
N/A
Revenue This Year
$20.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.42
N/A
Revenue Growth
16.24
N/A
52 Week Low
$4.90
$2.62
52 Week High
$8.25
$8.64

Technical Indicators

Market Signals
Indicator
ULBI
ACHV
Relative Strength Index (RSI) 29.08 46.50
Support Level $5.00 $5.84
Resistance Level $5.66 $8.63
Average True Range (ATR) 0.26 0.36
MACD -0.13 -0.18
Stochastic Oscillator 1.56 19.02

Price Performance

Historical Comparison
ULBI
ACHV

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: